Cite
Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies
MLA
Joshua R Barton, et al. Guanylyl Cyclase C as a Biomarker for Immunotherapies for the Treatment of Gastrointestinal Malignancies. Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0f8cb9a2c879e8667480f935b2f17f6b&authtype=sso&custid=ns315887.
APA
Joshua R Barton, John C. Flickinger, Jeffrey A. Rappaport, Trevor R. Baybutt, Amanda M. Pattison, Adam E. Snook, & Scott A. Waldman. (2021). Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies.
Chicago
Joshua R Barton, John C. Flickinger, Jeffrey A. Rappaport, Trevor R. Baybutt, Amanda M. Pattison, Adam E. Snook, and Scott A. Waldman. 2021. “Guanylyl Cyclase C as a Biomarker for Immunotherapies for the Treatment of Gastrointestinal Malignancies,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0f8cb9a2c879e8667480f935b2f17f6b&authtype=sso&custid=ns315887.